The Indian Council of Medical Research (ICMR) has come up with the national guidelines for gene therapy product development and clinical trials, aiming to ensure better treatment options for rare diseases or inherited genetic diseases, The Economic Times reported.
"These guidelines will provide the general principles for developing gene therapy products for any human ailment along with the framework for human clinical trials," said ICMR Director General Balram Bhargava.
According to Bhargava, both the Prime Minister’s Office and NITI Aayog were keen on having these guidelines in place and pushed to fast track the process.
The guidelines are expected to serve as a resource and roadmap for development of gene and cell therapies.
"We hope this will spur innovation and accelerate research into rare diseases in our nation," ICMR said.
To read more NewsPoints articles, click here.